Low Immunogenicity of Recombinant Hepatitis B Vaccine Derived from Hansenula polymorpha in Adults Aged Over 40 Years.

about

Low Immunogenicity of Recombinant Hepatitis B Vaccine Derived from Hansenula polymorpha in Adults Aged Over 40 Years.

Item

http://www.wikidata.org/entity/Q38928527

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Low Immunogenicity of Recombin ...... in Adults Aged Over 40 Years.

@en

type

Item

label

Low Immunogenicity of Recombin ...... in Adults Aged Over 40 Years.

@en

prefLabel

Low Immunogenicity of Recombin ...... in Adults Aged Over 40 Years.

@en

P1476

Low Immunogenicity of Recombin ...... in Adults Aged Over 40 Years.

@en

P2093

Fabiana Perez Rodrigues Bergamaschi

http://www.w3.org/2001/XMLSchema#string

Nativa Helena Alves Del-Rios

http://www.w3.org/2001/XMLSchema#string

Raquel Silva Pinheiro

http://www.w3.org/2001/XMLSchema#string

Sheila Araujo Teles

http://www.w3.org/2001/XMLSchema#string

P2860

Sex-based differences in immune function and responses to vaccination.

Hepatitis B: Epidemiology and prevention in developing countries.

Characterization of an age-response relationship to GSK's recombinant hepatitis B vaccine in healthy adults: An integrated analysis

Population-Based Multicentric Survey of Hepatitis B Infection and Risk Factors in the North, South, and Southeast Regions of Brazil, 10-20 Years After the Beginning of Vaccination.

The global impact of vaccination against hepatitis B: a historical overview.

Hepatitis B vaccines: protective efficacy and therapeutic potential.

Distribution of hepatitis B infection in Brazil: the epidemiological situation at the beginning of the 21 st century.

High non-responsiveness of males and the elderly to standard hepatitis B vaccination among a large cohort of healthy employees.

Immune response to hepatitis B vaccine in a group of health care workers in Sri Lanka.

Age is an important determinant in humoral and T cell responses to immunization with hepatitis B surface antigen.

P304

118-121

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4269/AJTMH.16-0475

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

M A Carneiro

Karlla Antonieta Amorim Caetano

P577

2016-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27799647

http://www.w3.org/2001/XMLSchema#string

P932

5239676

http://www.w3.org/2001/XMLSchema#string